Oligomerix Publishes Preclinical Data on Novel Small Molecule Therapeutic in Development for Alzheimer s Disease and Rare Neurodegenerative Diseases streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Oligomerix Awarded $3 35M from NIH to Support Clinical Development of Tau-Targeting Alzheimer s Disease Therapy streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.